| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b07e07ae7918451a573516faeaf0a08f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0612 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M31-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
| filingDate |
2020-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6ba4a1fe8065fa82a7f65bd80a83b7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9fbb26b500b15b0b45f1ebdbb468153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5fc678be202d87fadc4275711c05113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf7dad26ca4ae7ffdfa8e5f6fe7b62c1 |
| publicationDate |
2022-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2020204427-B2 |
| titleOfInvention |
Drug eluting ocular implant |
| abstract |
An drug delivery ocular implant comprising: an outer shell having an open first end and a nclosed second end, the outer shell configured to contain at least one drug; a cap configured to nbe joined with the outer shell at the open first end to form an interior space, the cap having at nleast one region of drug release, the at least one region of drug release comprising at least one norifice, a permeable or semi-permeable membrane or a coating within the interior space, nwherein a permeability of the membrane or the coating is configured to at least partially ncontrol the rate of elution of the at least one drug through the at least one region of drug nrelease to a region within an eye. n90n1/56 nN nN K1 nN nN nN |
| priorityDate |
2009-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |